טוען...
THE SEVERITY OF BLEEDING AND MORTALITY IN TRAUMA PATIENTS TAKING DABIGATRAN
BACKGROUND: Dabigatran, a direct thrombin inhibitor, has been shown to be more effective than warfarin in the prevention of stroke in patients with atrial fibrillation. Until recently, it lacked a reversal agent, and its contribution to the risk of transfusion in injured patients is unknown. OBJECTI...
שמור ב:
| הוצא לאור ב: | J Emerg Med |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482216/ https://ncbi.nlm.nih.gov/pubmed/27364823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jemermed.2016.05.005 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|